What Doctors Don't Tell YouThe breast cancer drug tamoxifen-marketed in the UK as Emblon, Noltam and Tamofen, and as Nolvadex in the US and the UK-has been enjoying some favourable press comment recently. ...
American drug regulators look like opening the floodgates on the use of the breast cancer drug tamoxifen. It is about to be licensed in the US as a preventative and there's a good chance the UK m ...
The reputation of the breast cancer drug tamoxifen has taken another serious knock following the publication of two European trials that show it is not a cancer preventative. ...
This month, the instructive case study about terrible doctoring comes from my own back yard. ...
New evidence from two studies show that women who take tamoxifen to prevent or treat breast cancer are at greater risk of endometrial abnormalities, including cancer. ...
Recently, you probably saw the newspaper articles about "new fears" raised by tamoxifen, the drug used to prevent and treat breast cancer. The stories concerned a Dutch case control study publish ...
Women who take tamoxifen to prevent breast cancer are getting too much of the drug, according to new evidence. ...
Many of the side effects of tamoxifen may be worth risking if you have cancer. However the risk/benefit equation changes considerably if you are healthy and offered the drug as a just in case mea ...
Yet another clinical trial of tamoxifen can’t decide if the drug is worth taking.
Originally hailed as a major contribution to breast cancer prevention, tamoxifen has had a bumpy ride
